43.14  0.77 (1.82%)		01-22 11:05
Open: 43.14 High: 44.09 Volume: 13,946		Pre. Close: 42.37 Low: 43.14 Market Cap: 39(M)

Short term
Mid term
Targets	6-month :	51.15	1-year :	59.75
Resists	First :	43.79	Second :	51.15
Pivot price	39.79
Supports	First :	39.11	Second :	36.21
MAs	MA(5) :	41.6	MA(20) :	39.66
	MA(100) :	32.76	MA(250) :	25.12
MACD	MACD :	1.1	Signal :	0.9
%K %D	K(14,3) :	96.9	D(3) :	92
RSI	RSI(14): 68.2
52-week	High :	43.79	Low :	13.42

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BBC ] has closed below upper band by 3.2%. Bollinger Bands are 57.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	42.42 - 42.58	42.58 - 42.75
Low:	40.91 - 41.11	41.11 - 41.3
Close:	42.05 - 42.35	42.35 - 42.66

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Wed, 21 Jan 2026
Trading Systems Reacting to (BBC) Volatility - Stock Traders Daily

Sat, 10 Jan 2026
How Virtus Lifesci Biotech Clinical Trials Etf (BBC) Affects Rotational Strategy Timing - Stock Traders Daily

Mon, 01 Dec 2025
Biotech ETF (BBC) Hits New 52-Week High - December 1, 2025 - Zacks Investment Research

Tue, 25 Nov 2025
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - Yahoo Finance

Mon, 17 Nov 2025
Best-Performing ETFs of Last Week - Zacks Investment Research

Tue, 28 Oct 2025
Biotech ETF (BBC) Hits New 52-Week High - Nasdaq

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.